Hello everyone,
July 2024 – Diagnosis: breast cancer ER+ / HER2 negative, with lymph node involvement, no metastases, stage IIIA. I had a CT, MRI, and PET-CT before starting chemotherapy.
August 2024 – I started chemotherapy, but before that I measured CA 15-3, which was elevated at 74 U/ml. It increased up to 92 halfway through the treatment, but returned to normal limits after I finished chemotherapy (24 U/ml).
After chemo, I had surgery, and before starting radiotherapy I checked it again – it was 21 U/ml. The next measurement was done 6 weeks after radiotherapy, before starting the first cycle of Ribociclib, and CA 15-3 had risen slightly to 24 U/ml.
I started Ribociclib preventively, because I have a high risk of recurrence. I tested the marker again after the first cycle of Ribociclib, when it had increased to 29, and again after the second cycle of Ribociclib, when it rose to 34.6 U/ml.
These increases make me quite anxious.
Are there other people in stage III who have experienced a rise in tumor marker after starting Ribociclib (Kisquali) or Abemaciclib (Verzenio), without this being associated with the appearance of metastases?
Wishing you all good health!